SASusana Arrigain

Susana Arrigain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Susana Arrigain has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Jesse D. Schold

    Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

    17 shared publications
  • Rocio Lopez

    Division of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Colorado Center for Transplantation Care (CCTCARE), Research and Education, Division of Transplant Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado, Aurora, Colorado

    14 shared publications
  • Deena Brosi

    Division of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Colorado Center for Transplantation Care (CCTCARE), Research and Education, Division of Transplant Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado, Aurora, Colorado

    10 shared publications
  • Sumit Mohan

    Division of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York

    9 shared publications
  • Ryan LaVanchy

    Division of Transplant Surgery, Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Colorado Center for Transplantation Care (CCTCARE), Research and Education, Division of Transplant Surgery, Department of Surgery, Anschutz Medical Campus, University of Colorado, Aurora, Colorado

    7 shared publications
  • Elizabeth Anne Pomfret

    University of Colorado School of Medicine

    6 shared publications

Latest Publications

  • Candidates for liver transplant with high-frequency deceased donor offers

    by Jesse D. Schold, Susana Arrigain, Sumit Mohan, S. Ali Husain, Miko Yu, Rocio Lopez, Deena Brosi, Ryan LaVanchy, Thomas Pshak, James R. Burton, et al.

    Changes in organ allocation, technology, and regulatory policy have led to significant increases in deceased donor liver offers for transplantation. Expansion of potential donors is associated with inefficiencies, including increased liver nonutilization, resources, and complications. We evaluated the contribution of individual waitlisted candidates to the national allocation of deceased donor liver offers to understand characteristics of candidates with numerous offer turndowns. We performed an observational cohort study of the Scientific Registry of Transplant Recipients, including deceased donor liver offers in the United States between January 1, 2021, and December 31, 2024. We used standard and hierarchical multivariable logistic models to evaluate factors associated with high-frequency candidates (HFCs). There were 1,021,569 offers of 32,750 deceased donor livers to 55,124 waitlisted candidates with ≥1 offer. Waitlisted candidates had 10.4 months average waitlist follow-up and received a median of 9 (IQR=[4, 22]) offers. However, 46% of offers (n=468,699) went to 10% (HFC, n=5726), who had ≥45 offers over the period. HFC were disproportionally ages 18–39 (adjusted odds ratio [AOR]=1.58, 95% CI=1.33–1.86, relative to 70+), Black (AOR=1.31, 95% CI: 1.17–1.47, relative to White), type-O blood (AOR=1.14, 95% CI: 1.07–1.21, relative to type A), body mass index ≥35 kg/m 2 (AOR=1.17, 95% CI: 1.06–1.28, relative to body mass index=20–24 kg/m 2 ), MELD 12–17 (AOR=1.24, 95% CI: 1.15–1.34, relative to >25), metabolic dysfunction (AOR=1.32, 95% CI: 1.09–1.62, relative to cirrhosis) and history of portal vein thrombosis (AOR=1.34, 95% CI: 1.23–1.46). There was significant heterogeneity in HFC by transplant center (median=8%, IQR=[3%, 13%]), and centers with higher proportions of HFC had lower transplant rates and offer acceptance ratios ( p <0.001). HFCs who received transplants had fewer living donor transplants and transplanted with older age donors. Results indicate liver donor offers are disproportionately explained by a minority of candidates. Efforts to identify reasons for repetitive offer declines, strategic use of offer filters and transition of applicable candidates to inactive status may dramatically improve the efficiency of deceased donor liver allocation.

  • Out-of-sequence lung allocation and outcomes for bypassed candidates in the United States

    by Elizabeth J. Bashian, Thomas F. O’SHea, Susana Arrigain, Rocio Lopez, Jesse D. Schold, Alison H. Mungo, Elizabeth A. David, Alice L. Gray, Jordan R.H. Hoffman, Michael T. Cain

  • Contribution of donor hospital characteristics to deceased donor organ recovery rates

    by Rocio Lopez, Sumit Mohan, Emily A. Vail, James R. Rodrigue, Susana Arrigain, Deena Brosi, Ryan LaVanchy, Trevor Nydam, Jesse D. Schold


  • How contemporary living kidney donor transplants compare to prepandemic trends: An interrupted time series analysis

    by Deena N. Brosi, Rocio Lopez, Susana Arrigain, Ryan LaVanchy, James Cooper, Jesse D. Schold

  • Outcomes of Deceased Donor Kidney Transplants Allocated Out of Sequence in the United States

    by Anne M. Huml, Joshua J. Augustine, Emilio D. Poggio, Alvin Wee, Susana Arrigain, Rocio Lopez, Jesse D. Schold

    Key Points: We used national data to examine the outcomes of kidney transplant allocated as out of sequence offers to transplant centers in the United States. Short-term kidney graft failure does not differ between kidneys that were allocated as out of sequence offers versus standard allocation. Background: Changes in kidney allocation policies and regulations of Organ Procurement Organizations have affected the volume of organ offers and challenged transplant providers. One consequence is increased kidneys allocated out of sequence (OOS). Methods: Retrospective observational study using Scientific Registry of Transplant Recipient data from 2021 to 2023, we analyzed donor and recipient characteristics for OOS versus standard kidney allocation and multivariable Cox models to evaluate graft survival. We also compared paired donors (one kidney OOS and the other standard allocation). Results: Annual OOS kidney allocation rates increased from 5.4% in 2021 to 18.4% in 2023. High OOS-use centers increased from 5 (2.2%) between 2021 and June 2022 to 37 (17%) in 2023. Listing at a high-OOS usage center was associated with increased rate of deceased donor transplantation (adjusted hazard ratio [AHR], 3.07; 95% confidence interval [CI], 2.90 to 3.25). Recipients of OOS allocation were more likely to be male (66% versus 59%), White race (38% versus 32%), privately insured (29% versus 24%), and preemptively transplanted (18% versus 10%). Overall graft loss was not significantly different between OOS and standard allocated transplants (AHR, 0.94; 95% CI, 0.85 to 1.05), consistent in paired donor analysis (AHR, 1.10; 95% CI, 0.86 to 1.41). Conclusions: Short-term kidney graft failure does not differ between OOS and standard allocation. High-OOS kidney centers have higher deceased donor transplant rates. Further investigation is needed to understand demographic differences and factors explaining OOS allocation.


  • Open Access

    Evaluation of the stability of organ procurement organization performance metrics

    by Rocio Lopez, Sumit Mohan, James R. Rodrigue, Susana Arrigain, Deena Brosi, Ryan Lavanchy, David Zingmond, Bruce Kaplan, Elizabeth A. Pomfret, Jesse D. Schold


  • Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States

    by Jesse D. Schold, Susana Arrigain, S. Ali Husain, Miko Yu, Rocio Lopez, Deena Brosi, Ryan LaVanchy, Sumit Mohan

    Key Points: In 2023, national policy mandated that kidney transplant centers identify Black candidates for potential waitlist priority modification. Overall, 32% of Black candidates received modification with significant variation by candidate characteristics and transplant center. Candidates who received modification had close to three-fold higher rates of deceased donor transplantation. Background: In 2023, kidney transplant programs in the United States were mandated by the Organ Procurement and Transplantation Network (OPTN) to identify all Black candidates on their kidney waiting lists and evaluate potential modifications of waiting time. This mandate was the result of established differences in eligibility for candidates to receive priority for donor offers based on race-neutral and race-inclusive eGFR. The policy went into effect on January 5, 2023, and required submission of appropriate modifications with a deadline of January 3, 2024. Methods: We included OPTN data for adult Black candidates on the kidney and kidney/pancreas transplant waiting lists in the United States between January 6, 2023, and December 31, 2023. We evaluated incidence of wait time modifications based on eGFR, characterized candidates with and without modifications, heterogeneity in center-level implementation of eGFR modifications, and the association of modification with time to deceased donor transplantation using multivariable generalized estimating equations and Cox models. Results: Overall, 32% (14,419/44,912) of Black candidate listings received an eGFR modification of waiting time priority. In multivariable analysis, candidates with modifications were older (compared with candidates aged 18–49, ages 65–69 and 70+ had adjusted odds ratio [aOR]=1.60 [95% confidence interval (CI), 1.49 to 1.72] and 1.52 [95% CI, 1.40 to 1.66] respectively), female (aOR=1.09, 95% CI, 1.04 to 1.14), and preemptively placed on the waiting list (aOR=2.58, 95% CI, 2.46 to 2.72). Kidney-alone candidates (versus kidney-pancreas candidates), candidates with higher body mass index, and prior transplant recipients also had higher adjusted likelihood of waiting time modification. The median increase in qualifying priority days for candidates was 610 (interquartile range=330–1049). Waitlist modification was associated with a significantly higher rate of deceased donor transplantation (adjusted hazard ratio=2.85 [95% CI, 2.70 to 3.02]). There was significant variation by transplant center in the proportion of prevalent patients with modifications (median=31%, interquartile range=11%–45%). Conclusions: There was significant patient- and center-level variation in the implementation of eGFR modifications and a higher rate of transplantation for candidates who received modifications.


  • Open Access

    Association of the initial implementation of continuous distribution allocation policy with outcomes for lung transplant candidates by blood type

    by Jesse D. Schold, Jordan R.H. Hoffman, Sumit Mohan, Alice L. Gray, Rocio Lopez, Susana Arrigain, Deena Brosi, Ryan LaVanchy, S. Ali Husain, Miko Yu, et al.


  • Open Access

    Authors’ reply to letter regarding “Association of organ procurement organization volume with CMS performance evaluations”

    by Rocio Lopez, Sumit Mohan, James R. Rodrigue, Susana Arrigain, Deena Brosi, Ryan Lavanchy, Bruce Kaplan, Elizabeth A. Pomfret, Jesse D. Schold

  • Open Access

    Association of organ procurement organization volume with Centers for Medicare and Medicaid Services performance evaluations

    by Rocio Lopez, Sumit Mohan, James R. Rodrigue, Susana Arrigain, Deena Brosi, Ryan Lavanchy, Bruce Kaplan, Elizabeth A. Pomfret, Jesse D. Schold